All
1.
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
Pilar Blay, Iñigo Santamaría, Ana S Pitiot, María Luque, Marta G Alvarado, Ana Lastra, Yolanda Fernández, Ángeles Paredes, José MP Freije, Milagros Balbín BMC Cancer 2013, 13 :243 (17 May 2013)
Abstract | Provisional PDF
2.
Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population
Tianbo Jin, Xiaolan Li, Jiayi Zhang, Hong Wang, Tingting Geng, Gang Li, Guodong Gao, Chao Chen BMC Cancer 2013, 13 :236 (12 May 2013)
Abstract | Full text | PDF
| PubMed
3.
Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility
Peng Zhao, Peng Zou, Lin Zhao, Wei Yan, Chunsheng Kang, Tao Jiang, Yongping You BMC Cancer 2013, 13 :234 (10 May 2013)
Abstract | Full text | PDF
| PubMed
4.
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
Cihan Cetinkaya, Tommy Martinsson, Johanna Sandgren, Catarina Träger, Per Kogner, Jan Dumanski, Teresita Díaz de Ståhl, Fredrik Hedborg BMC Cancer 2013, 13 :231 (9 May 2013)
Abstract | Provisional PDF
| PubMed
5.
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
Alexa J Resler, Kathleen E Malone, Lisa G Johnson, Mari Malkki, Effie W Petersdorf, Barbara McKnight, Margaret M Madeleine BMC Cancer 2013, 13 :219 (1 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
6.
Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection
Giada V Zapparoli, Robert N Jorissen, Chelsee A Hewitt, Michelle McBean, David A Westerman, Alexander Dobrovic BMC Cancer 2013, 13 :206 (24 April 2013)
Abstract | Provisional PDF
| PubMed
7.
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
Olfa Derbel, Qing Wang, Françoise Desseigne, Michel Rivoire, Pierre Meeus, Patrice Peyrat, Mattia Stella, Isabelle Martel-Lafay, Anne-Isabelle Lemaistre, Christelle de La Fouchardière BMC Cancer 2013, 13 :200 (23 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma
Masao Honda, Taro Yamashita, Tatsuya Yamashita, Kuniaki Arai, Yoshio Sakai, Akito Sakai, Mikiko Nakamura, Eishiro Mizukoshi, Shuichi Kaneko BMC Cancer 2013, 13 :191 (15 April 2013)
Abstract | Provisional PDF
| PubMed
9.
TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient
Juliana Giacomazzi, Simone Selistre, Juliana Duarte, Jorge Pinto Ribeiro, Paulo JC Vieira, Gabriel de Souza Macedo, Cristina Rossi, Mauro Czepielewski, Cristina Brinkmann Oliveira Netto, Pierre Hainaut, Patricia Ashton-Prolla BMC Cancer 2013, 13 :187 (9 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
10.
Expressional alterations in functional ultra-conserved non-coding rnas in response to all -trans retinoic acid - induced differentiation in neuroblastoma cells
Karen M Watters, Kenneth Bryan, Niamh H Foley, Maria Meehan, Raymond L Stallings BMC Cancer 2013, 13 :184 (8 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
